人工血管移植物不增加腘动脉瘤开放修复术后不良结局
多中心回顾性研究纳入1999至2020年101例腘动脉瘤开放隔离+旁路术患者,中位随访4.2年。人工血管组与自体大隐静脉组主要不良肢体事件(MALE)无显著差异(log rank P=0.47),急诊手术与MALE相关(HR 5.73),人工血管使用及术后抗凝与MALE无关。
要点
- 人工血管旁路与自体大隐静脉旁路的MALE无显著差异(log rank P=0.47)
- 急诊旁路与MALE相关(HR 5.73,95%CI 2.07-15.85,P<0.001)
- 人工血管使用与MALE无关(HR 1.00,95%CI 0.40-2.51,P=0.99)
核心结论
- 腘动脉瘤开放修复术长期结局良好,人工血管旁路可作为自体血管的替代选择,缺乏合适大隐静脉不应妨碍有指征的开放手术修复。
研究设计与样本
- 五个地区医院的多中心数据库回顾性分析,纳入1999至2020年101例腘动脉瘤开放隔离+旁路术患者,中位随访4.2年(四分位距1.3-7.4年),99例(98.0%)数据完整。
主要发现
- 人工血管组患者年龄大于大隐静脉组(72 vs 66岁,P=0.001),合并症率相似。
- 人工血管组术后抗凝比例高于大隐静脉组(60.7% vs 23.2%,P<0.001)。
- 移植物类型不影响术后并发症发生率(各项P=NS)。
- 总体MALE率低(2年19.2%),按移植物类型分层无显著差异(log rank P=0.47)。
- 多变量分析中急诊旁路与MALE相关(HR 5.73,95%CI 2.07-15.85,P<0.001),人工血管使用(HR 1.00,95%CI 0.40-2.51,P=0.99)和术后抗凝(HR 1.02,95%CI 0.42-2.50,P=0.97)与MALE无关。
关键数值与推荐
- MALE定义为同侧重大截肢或为移植物通畅而再次干预。
- 旁路移植物包括大隐静脉(69.7%)、人工血管(28.3%)和2例(2.0%)替代移植物(1例拼接臂静脉,1例冷冻保存静脉)。
- 所有手术均采用内侧入路,膝下腘动脉为旁路靶点(100%)。
- 急诊手术占11.1%,择期手术占88.9%。
临床怎么用
- 作者认为,对于膝下腘动脉旁路靶点,人工血管旁路是自体血管的可比替代选择,缺乏合适大隐静脉不应妨碍有指征的开放手术修复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single segment, greater saphenous vein (GSV) conduit is considered the optimal bypass conduit among patients undergoing bypass surgery for peripheral artery disease (PAD). While this data has been extrapolated to patients undergoing bypass for popliteal artery aneurysms (PAAs), the pathophysiology of PAA is inherently different when compared to PAD, and the impact of conduit type on long-term outcomes after open repair of PAA remains unclear. METHODS: A multicenter database of five regional hospitals was retrospectively reviewed for all patients with PAA undergoing open surgical repair. Data were collected on demographic information, operative details, medications, and postoperative outcomes. Kaplan-Meier curves were used to compare freedom from major adverse limb events (MALE) following GSV versus prosthetic bypass. Cox proportional hazards model was used to identify patient-level characteristics associated with MALE, which was defined as major ipsilateral limb amputation or reintervention for graft patency. RESULTS: From 1999 to 2020, a total of 101 patients with PAA underwent open exclusion and bypass surgery. Median follow-up period was 4.2 years (interquartile range, 1.3-7.4 years), and complete data were available for 99 (98.0%) patients. The majority of patients were male (99.0%) and Caucasian (93.9%). Only 11.1% of procedures were emergent, with the remainder (88.9%) being elective. All patients underwent medial exposure with a below-knee popliteal bypass target (100%). Bypass conduits included GSV (69.7%), prosthetic conduit (28.3%), and 2 (2.0%) alternative conduits (one spliced arm vein, one cryopreserved vein). Patients undergoing prosthetic bypass were older (72 vs. 66 years, P = 0.001) and had similar rates of medical comorbidities. Compared with the GSV group, patients with prosthetic conduits were more frequently placed on postoperative anticoagulation (60.7% vs. 23.2%, P < 0.001). Conduit type did not impact postoperative complication rates (P = NS each). MALE rates were low overall (19.2% at 2 years), and similar when stratified by conduit type (log rank P = 0.47). On multivariable analysis, emergent bypass was associated with MALE (hazard ratio [HR] 5.73, 95% confidence interval [CI] 2.07-15.85, P < 0.001). Prosthetic conduit usage (HR 1.00, 95% CI, 0.40-2.51, P = 0.99) and postoperative anticoagulation (HR 1.02, 95% CI 0.42-2.50, P = 0.97) were not associated with MALE. CONCLUSIONS: Open repair of PAA is associated with excellent long-term outcomes. Prosthetic bypass is a comparable alternative to autogenous conduit for below-knee popliteal bypass targets, and lack of suitable GSV should not prohibit open surgical repair when indicated.
引用
- Kim Y, Loanzon RS, Southerland KW, et al. Prosthetic Conduit Use Does Not Adversely Impact Outcomes after Open Repair of Popliteal Artery Aneurysms. Ann Vasc Surg. 2023. PMID: 37858670. doi:10.1016/j.avsg.2023.08.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。